Back to top

Galmed Pharmaceuticals Wins Nasdaq Extension to Regain $1 Bid Price Compliance

Galmed Pharmaceuticals ( ($GLMD) ) has shared an announcement. On July 30, 2026, Galmed Pharmaceuticals reported it had received a notice from Nasd...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Galmed Pharmaceuticals Ltd. (GLMD)